APA (7th ed.) Citation

Younoussa, A., Samidine, S. N., Bergeman, A. T., Piubello, A., Attoumani, N., Grillone, S. H., . . . Hasker, E. (2023). Protocol, rationale and design of BE-PEOPLE (Bedaquiline enhanced exposure prophylaxis for LEprosy in the Comoros): A cluster randomized trial on effectiveness of rifampicin and bedaquiline as post-exposure prophylaxis of leprosy contacts. BMC infectious diseases, 23(1), 310-9. https://doi.org/10.1186/s12879-023-08290-0

Chicago Style (17th ed.) Citation

Younoussa, Assoumani, et al. "Protocol, Rationale and Design of BE-PEOPLE (Bedaquiline Enhanced Exposure Prophylaxis for LEprosy in the Comoros): A Cluster Randomized Trial on Effectiveness of Rifampicin and Bedaquiline as Post-exposure Prophylaxis of Leprosy Contacts." BMC Infectious Diseases 23, no. 1 (2023): 310-9. https://doi.org/10.1186/s12879-023-08290-0.

MLA (9th ed.) Citation

Younoussa, Assoumani, et al. "Protocol, Rationale and Design of BE-PEOPLE (Bedaquiline Enhanced Exposure Prophylaxis for LEprosy in the Comoros): A Cluster Randomized Trial on Effectiveness of Rifampicin and Bedaquiline as Post-exposure Prophylaxis of Leprosy Contacts." BMC Infectious Diseases, vol. 23, no. 1, 2023, pp. 310-9, https://doi.org/10.1186/s12879-023-08290-0.